| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/25/2003 | WO2002072880A3 Method for detecting cytosine methylation patterns having high sensitivity |
| 09/25/2003 | WO2002068647A3 Proteins, polynucleotides encoding them and methods of using the same |
| 09/25/2003 | WO2002068472A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/25/2003 | WO2002064634A3 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 09/25/2003 | WO2002064612A9 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 09/25/2003 | WO2002063004A3 G-protein coupled receptors |
| 09/25/2003 | WO2002062135A3 Scce modified transgenic mammals and their use as models of human disease |
| 09/25/2003 | WO2002061128A3 Method of determining a chemotherapeutic regimen based on ercc1 expression |
| 09/25/2003 | WO2002055688A8 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms |
| 09/25/2003 | WO2002053587A3 Polypeptide inducing hiv-neutralising antibodies |
| 09/25/2003 | WO2002046419A3 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 09/25/2003 | WO2002038792A3 Novel method for analysing phenotypic characteristics of human immunodeficiency virus (hiv) |
| 09/25/2003 | WO2002036788A3 Nucleic acids and polypeptides specifically expressed in cells of the transfer zone of a plant seed and uses thereof |
| 09/25/2003 | WO2002036622A3 GαqPROETIN VARIANTS AND THEIR USE IN THE ANALYSIS AND DISCOVERY OF AGONISTS AND ANTAGONISTS OF CHEMOSENSORY RECEPTORS |
| 09/25/2003 | WO2002034926A3 Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars |
| 09/25/2003 | WO2002031203A3 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 09/25/2003 | WO2002031146A3 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 09/25/2003 | WO2002030964A3 Comparative ligand mapping from mhc positive cells |
| 09/25/2003 | WO2002028355A3 Methods and compositions for enhancing angiogenesis |
| 09/25/2003 | WO2002027029A3 Method for determining relative abundance of nucleic acid sequences |
| 09/25/2003 | WO2002026982A3 Secreted human proteins |
| 09/25/2003 | WO2002026949A3 Human proteases and polynucleotides encoding the same |
| 09/25/2003 | WO2002026816A3 Lymphoma associated molecules and uses therefor |
| 09/25/2003 | WO2002024911A3 63760, a novel human transporter and uses thereof |
| 09/25/2003 | WO2002024910A3 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 09/25/2003 | WO2002022874A3 Oligonucleotides for labeling oligonucleotide probes and proteins |
| 09/25/2003 | WO2002020846A3 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure |
| 09/25/2003 | WO2002020754A3 Molecules for diagnostics and therapeutics |
| 09/25/2003 | WO2002016420A3 Antiviral compounds derived from the hsv gd protein and methods |
| 09/25/2003 | WO2002014489A9 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 09/25/2003 | WO2002012561A3 Haplotypes of the or1g1 gene |
| 09/25/2003 | WO2002011674A3 Method and reagent for the inhibition of calcium activated chloride channel-1 (clca-1) |
| 09/25/2003 | WO2002010378A3 Antisense modulation of ptp1b expression |
| 09/25/2003 | WO2002010364A3 Methods for enhancing targeted gene alteration using oligonucleotides |
| 09/25/2003 | WO2002008425A3 Haplotypes of the adrb3 gene |
| 09/25/2003 | WO2002005634A3 Transgenic animal and methods |
| 09/25/2003 | WO2002003790A3 Transgenic mice containing targeted kinase gene disruptions |
| 09/25/2003 | WO2001077155A3 Orfx polynucleotides and polypeptides |
| 09/25/2003 | US20030182692 Protein kinase stress-related polypeptides and methods of use in plants |
| 09/25/2003 | US20030182691 Modification of pollen coat protein composition |
| 09/25/2003 | US20030182690 Banana and melon promoters for expression of transgenes in plants |
| 09/25/2003 | US20030182689 DNA molecules and the amino acid encoded by the DNA molecules, which are critical to male fertility, a promoter and the essential sequences ofthe DNA is identified and using such DNA molecule to mediate fertility in plants; hybrid |
| 09/25/2003 | US20030182688 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 09/25/2003 | US20030182687 Functionalization of carotenoid compounds |
| 09/25/2003 | US20030182686 Transforming a grape plant cell with a nucleic acid molecule which encodes a cecropin B peptide, wherein expression of B peptide,increaes resistance to bunch rot disease caused by botrytis |
| 09/25/2003 | US20030182685 Transgenic plants expressing photorhabdus toxin |
| 09/25/2003 | US20030182684 Tobacco rattle virus vectors and related compositions and methods |
| 09/25/2003 | US20030182683 Isolated DNA molecule encoding a fragment of an Erwinia hypersensitive response elicitor protein or polypeptide, to elicit hypersensitive response in the plants |
| 09/25/2003 | US20030182682 Bacillus crystal proteins having improved insecticidal activity; immunodetection kits; transgenic plants |
| 09/25/2003 | US20030182681 Introducing into a eukaryotic cell a cytotoxic Pseudomonas protein to cause the cell death; disease resistance plant |
| 09/25/2003 | US20030182680 Gene involved in pyrimidine biosynthesis in plants |
| 09/25/2003 | US20030182679 Reducing homogentisate degradation by reducing the activity of homogentisate 1,2-dioxygenase (HGD), maleyl-acetoacetate isomerase(MAAI) and/or fumaryl acetoacetate hydrolase(FAAH) activity |
| 09/25/2003 | US20030182678 Multigene expression vectors for the biosynthesis of products via multienzyme biological pathways |
| 09/25/2003 | US20030182676 A reporter gene, the transcription of which is inducible by natural or synthetic molecule which modulate the activity of such reporter, is incorporated into the genome of the animal to produce nonhuman transgenic animal |
| 09/25/2003 | US20030182675 Functional disruption of avian immunoglobulin genes |
| 09/25/2003 | US20030182674 Method of making a genetically modified mammal |
| 09/25/2003 | US20030182673 Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto |
| 09/25/2003 | US20030182672 Genetic silencing |
| 09/25/2003 | US20030182671 Method of constructing mouse suitable for the take, differentiation and proliferation of heterogenous cells, mouse constructed by this method and use of the mouse |
| 09/25/2003 | US20030182670 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| 09/25/2003 | US20030182668 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors |
| 09/25/2003 | US20030182667 Type iii allergic inflammation model animal |
| 09/25/2003 | US20030182066 Method and processing gene expression data, and processing programs |
| 09/25/2003 | US20030181712 Reagents for oligonucleotide cleavage and deprotection |
| 09/25/2003 | US20030181710 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 09/25/2003 | US20030181706 Inflammation-associated polynucleotides |
| 09/25/2003 | US20030181693 Increased nuclease resistance, enhanced binding affinity and improved protein binding; side effect reduction |
| 09/25/2003 | US20030181692 207 human secreted proteins |
| 09/25/2003 | US20030181687 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 09/25/2003 | US20030181664 For modulating cytokine, interferon, and tumor necrosis factor levels |
| 09/25/2003 | US20030181663 Human stanniocalcin-alpha |
| 09/25/2003 | US20030181662 Human procalcitonin and the preparation and use thereof |
| 09/25/2003 | US20030181661 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 09/25/2003 | US20030181659 Thrombopoietin receptor modulating peptide |
| 09/25/2003 | US20030181658 Exhibit protease activity as a single chain or as an activated two chain form; use of polypeptides to identify compounds that modulate the protease activity thereof and as tumor markers |
| 09/25/2003 | US20030181413 Raf protein kinase therapeutics |
| 09/25/2003 | US20030181410 Methods for encapsulating plasmids in lipid bilayers |
| 09/25/2003 | US20030181408 Inhibiting gene expression by an antisense nucleic acid, drug screening a candidate compound for antiproliferative agents, microbiocides; finding antibiotics treating drug resistant bacteria |
| 09/25/2003 | US20030181406 Immunostimulants, synthetic oligonucleotide or polynucleotide for treating infectious diseases, allergy, asthma, cancer, anemia, thrombocytopenia, or neutropenia |
| 09/25/2003 | US20030181405 Interferon alpha plasmids and delivery systems, and methods of making and using the same |
| 09/25/2003 | US20030181404 Inhibiting cell growth with a genetic engineered kinase |
| 09/25/2003 | US20030181403 A gene therapy for cancers, comprising a cancer suppressing gene; genetic engineering, duplicated gene, cloned gene |
| 09/25/2003 | US20030181382 Protein fragments which have antiviral activity, and particularly relates to HIV peptides derived from the HIV transmembrane glycoprotein (gp41) which inhibit HIV-induced cell-cell fusion. This invention further relates to methods |
| 09/25/2003 | US20030181381 Factor X analogues having a modified protease cleavage site |
| 09/25/2003 | US20030181379 Novel fibroblast growth factor (FGF23) and methods for use |
| 09/25/2003 | US20030181378 Protein having amino acid sequence in SEQ ID No.: 1 of the Sequence Listing derived from human MP52, and a dimer protein homodimer protein described above can be obtained by constructing a plasmid containing DNA coding amino acid |
| 09/25/2003 | US20030181376 Control of crop pests & animal parasites through direct neuronal uptake |
| 09/25/2003 | US20030181369 Method of modulating glycosylation pathways |
| 09/25/2003 | US20030181368 Kappa-A conopeptides and uses thereof |
| 09/25/2003 | US20030181367 Membrane translocation peptides, compositions comprising them, chimeric molecules comprising them, and methods of using them to achieve transmembrane transport of various agents. |
| 09/25/2003 | US20030181364 Genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions. |
| 09/25/2003 | US20030181362 Receptor |
| 09/25/2003 | US20030181360 Human TSLP DNA and polypeptides |
| 09/25/2003 | US20030180953 Gene disruption methodologies for drug target discovery |
| 09/25/2003 | US20030180951 Inserting DNA into plant cell to transform the plant cell with agitation |
| 09/25/2003 | US20030180950 Reversible masking of liposomal complexes for targeted delivery |
| 09/25/2003 | US20030180949 Avoidance of undesirable replication intermediates in plasmid propagation |
| 09/25/2003 | US20030180948 Superficial zone protein and methods of making and using same |
| 09/25/2003 | US20030180947 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 09/25/2003 | US20030180946 Site-specific cell perforation technique |